膀胱移行细胞癌分子生物学标记物研究进展
Research Progress of Molecular Biomarkers in Transitional Cell Carcinoma of Bladder
摘要
与临床病理学相比,肿瘤分子生物学标记为肿瘤生物学行为的分析、治疗方式的选择、临床预后的判断提供了更客观、更丰富的信息,全文就目前国内外对膀胱移行细胞癌分子生物学标记物的研究概况作一综述。
出处
《中国肿瘤》
CAS
2006年第4期244-247,共4页
China Cancer
参考文献17
-
1Migaldi M, Rossi G, Maiorana A, et al. Superficial papillary urothelial carcinomas in young and elderly patients:a comparative study[J]. BJU Int, 2004, 94(3): 311-316.
-
2Yeniyol CO, Suelozgen T, Vardar E, et al. The relation of mutant p53 accumulation in transitional cell carcinoma of bladder with pathological stage, grade, recurrence and survival[J]. Int Urol Nephrol, 2001, 33(3): 473-478.
-
3Ong TA, Peh SC, Goh KS, et al. P53 protein expression in transitional cell carcinoma of the bladder-experience of the university of Malaya Medical Centre[J]. Asian J Surg,2003, 26(1): 31-36.
-
4Sanchez Zalabardo D, Rosell Costa D, Fernandez Montero JM, et al. Prognostic value of p53, Ki67, and Rb protein in infiltrating bladder tumors[J]. Actas Urol Esp, 2002, 26(2): 98-103.
-
5Shariat SF, Kim J, Raptidis G, et al. Association of p53and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder [J]. Urology,2003, 61(6): 1140-1145.
-
6Chatterjee SJ, Datar R, Youssefzadeh D, et al. Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma[J]. J Clin Oncol, 2004, 22(6):1007-1013.
-
7Liukkonen T, Lipponen P, Raitanen M, et al. Evaluation of p21^WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer[J]. Urol Res, 2000, 28(5):285 -292.
-
8Hitchings AW, Kumar M, Jordan S, et al. Prediction of progression in pTa and pT1 bladder carcinomas with p53,p16 and pRb[J]. Br J Cancer, 2004, 91(3): 552-557.
-
9Duggan B, Williamson K. Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?) [J]. Curr Opin Urol, 2004, 14(5): 277-286.
-
10Frank I, Cheville JC, Blute ML, et al. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement [J].Cancer, 2004, 101(8): 1803-1808.
-
1赵快乐,施学辉,蒋国梁.食管癌预后有关的分子生物学标记物[J].中国癌症杂志,2001,11(3):273-275. 被引量：3
-
2冉飞武,李建彬,于金明.与非小细胞肺癌预后相关的分子生物学标记物的研究现状[J].中国肿瘤临床与康复,2004,11(4):375-378. 被引量：1
-
3李加美,王强修,张珂,林晓燕.甲状腺乳头状癌分子标记物研究进展[J].中华临床医师杂志（电子版）,2012,6(23):7698-7700. 被引量：7
-
4朱信信,杨红鹰.三阴性乳腺癌相关分子标记物的表达及临床特征分析[J].诊断病理学杂志,2015,22(1):53-56. 被引量：10
-
5王惠忠,李勇,栾信庸.喉癌、下咽癌的分子生物学标记物[J].山东医大基础医学院学报,2002,16(2):123-125. 被引量：1
-
6黄二勇.神经母细胞瘤分子生物学标记物与临床预后判定[J].国外医学（儿科学分册）,1999,26(3):135-138.
-
7戴成林,刘会春.胆囊癌分子生物学的研究进展[J].安徽医药,2009,13(5):558-560. 被引量：1
-
8刘丹丹,易永芬,邓玮.maspin、p27、skp2在大肠肿瘤的表达及意义[J].世界华人消化杂志,2006,14(3):267-272. 被引量：5
-
9梁锐,王芳,王开昕,高倩,王志强,杨耘.MAGE-A1,-A4基因在大肠肿瘤中的表达及临床意义[J].世界华人消化杂志,2005,13(5):657-661. 被引量：2
-
10王陈.甲状腺肿瘤的分子生物学标记物[J].复旦学报（医学版）,2002,29(5):420-422.
